Tumor Immunotherapy and Microenvironment

Research output

Research output per year 2011 2015 2016 2017 2018 2020 2021 2022 2023 2025

• 63 Article
• 19 Review article
• 12 Chapter
• 8 Doctoral Thesis
• 12 More
  • 3 Comment/debate
  • 2 Meeting Abstract
  • 2 Editorial
  • 2 Letter
  • 1 Patent
  • 1 Master's Thesis
  • 1 Preprint

Research output per year

Research output per year

Search results

• 2023

  CyPep-1 reprograms the tumor microenvironment and enhances the efficacy of immune checkpoint inhibitors: Annals of Oncology

  Janji, B., Noman, M. Z., Hossain, J., Prestegarden, L., Pico-Navarro, C., Rigg, E., Bosseler, M. & Bjerkvig, R., Oct 2023, In: Annals of Oncology. 34, Suppl.2, p. S1180-S1180 2308P.

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2022

  VPS34 inhibitor SB02024 activates cGAS-STING signaling and sensitizes tumors to STING agonist

  Yu, Y., Noman, M. Z., Parpal, S., Kleinendorst, S. C., Saether, K. B., Alexeyenko, A., Viklund, J., Andersson, M., Martinsson, J., Tamm, K. P., De Milito, A. & Janji, B., 15 Jun 2022, In: Cancer Research. 82, 12_Supplement, p. 2116-2116 1 p., 2116.

  Research output: Contribution to journal › Meeting Abstract › peer-review